01 — At a Glance
The Financial Services Octopus That Just Got VC Money
- 52-Week High / Low₹369 / ₹155
- FY25 Revenue (Full Year)₹40,632 Cr
- FY25 PAT (Full Year)₹3,410 Cr
- Full-Year EPS (FY25)₹12.78
- Q3 FY26 EPS₹3.61
- Book Value₹123
- Price to Book2.66x
- Dividend Yield0.00%
- Debt / Equity4.86x
- Stock P/E24.1x
The Setup: Aditya Birla Capital is the holding company for all Aditya Birla Group’s financial services: a ₹1.48 lakh crore NBFC, housing finance growing at 58% YoY, asset management at ₹4.81 lakh crore AUM, life insurance doing 19% FYP growth, and health insurance now capturing 14.2% market share. Q3 FY26 delivered ₹966 crore standalone PAT (+40% QoQ). The stock has returned 103% in one year. Advent International just invested ₹2,750 crore into the housing finance subsidiary to fund two years of growth. The P/E is 24.1x. The best part? Management is still flying under the radar while every other financial services stock trades at 2x the multiples.
02 — Introduction
Welcome to the Most Chaotic Holding Company You’ve Probably Missed
Let’s start with what Aditya Birla Capital actually does. It’s not a bank. It’s not an insurance company. It’s not a mutual fund. It’s technically all of them, wrapped inside one corporate structure, held by Grasim Industries (68.58% stake), which itself is part of the Aditya Birla Group — one of India’s largest conglomerates.
Think of ABCL as a financial services ecosystem: you need a personal loan? NBFC. You need a home loan? Housing Finance subsidiary ABHFL. You want to invest ₹5 lakhs? Asset Management. You need life cover? Direct subsidiary ABSLI. Your family needs health insurance? Aditya Birla Health Insurance. One logo, five separate profitable businesses, zero dividend payout (yes, really), and the whole thing trades at 24x P/E.
The company has been quietly building this for a decade. Revenue has grown at 19.5% CAGR over the last five years. Profits have grown at 28.8% CAGR. Management says they’re on track to double the lending book in three years. An international PE firm literally just validated the housing finance unit at nearly ₹20,000 crore. And the stock has returned 103% in the last year while the broader market scratched its head wondering if there was any better option.
This is the story of a company running five separate gold-mine operations under one roof, using the parent company’s capital muscle, and watching the market price it like a regional state bank. Let’s dig in.
Concall Highlight (Feb 2026): “We’re driving quality and profitable growth by leveraging data, digital and technology.” Translation: We’ve automated our lending, we know exactly who defaults, and we’re hiring them anyway because we’re growing at 24% annually.
03 — Business Model: So… What Do They Actually Do?
Five Separate Profit Machines, One Holding Company, Zero Dividend
Aditya Birla Capital is an NBFC-Investment and Credit Company (NBFC-ICC) that owns six operational subsidiaries and JVs. Here’s the breakdown:
1. Lending Business (Aditya Birla Finance Ltd) — ₹1.48 lakh crore AUM. The company loans to small/medium businesses (56% of portfolio), large corporates (31%), and consumers (13%). It’s genuinely profitable: ₹772 crore PAT in Q3, 2.25% RoA, growing at 24% YoY. Cost of borrowing: 7.41%. They’re targeting 2.5% RoA within 4–5 quarters. You don’t fund loans by selling insurance; you fund them by borrowing from banks (40% of funding) and issuing bonds (36%). Classic NBFC playbook.
2. Housing Finance (ABHFL) — ₹42,204 crore AUM, up 58% YoY. Just crossed ₹40k crore milestone. They lend to home buyers at competitive rates. Q3 delivered ₹229 crore PBT with 14.94% RoE. Asset quality is ludicrous: Stage 2+3 is 0.95%, down 82 bps YoY. This unit is so attractive that Advent International just wrote a ₹2,750 crore cheque for 14.3% equity. For context: Advent doesn’t invest in mediocre real estate. ABHFL is clearly a crown jewel.
3. Life Insurance (ABSLI) — ₹97,286 crore AUM. One of India’s top-5 private life insurers. Q3 FY26 saw Individual FYP growth of 19%, group business bouncing back at 8% (after H1 degrowth), and net margins expanding to 14.6% (up 380 bps YoY). The solvency ratio is 210%. They’ve solved the insurance profitability paradox: traditional+protection products now comprise 70% of individual business (up from lower mix), which means better margins. Renewal premiums are up 18%.
4. Health Insurance (ABHI) — JV with Max Bupa — ₹4,956 crore GWP (9M FY26), +41% YoY. Market share just jumped from 12% to 14.2%, making them the #1 standalone health insurer. They’re still loss-making (net loss ₹178 crore in 9M), but combined ratio improved to 111%. The company is betting on “Health First” model — incentivizing customers for wellness, reducing claims through preventive care. It’s working: health-first customers have 8%+ lower loss ratios. Still unprofitable, but narrowing losses at hypergrowth rates is exactly what you want from a young insurer.
5. Asset Management (ABSLAMC) — ₹4.81 lakh crore average AUM, +20% YoY. Rank 6 in India. Mutual fund AUM is ₹4.43 lakh crore. But the real story is alternatives: PMS/AIF/Advisory assets jumped from ₹3,853 crore to ₹32,663 crore YoY (8x growth). This includes a ₹28,000 crore ESIC mandate — basically, India’s employees’ savings fund just handed ABSLAMC ₹28k crore to manage. Revenue was ₹562 crore (+16% YoY), with 20% PAT growth.
Lending AUM₹1.48 Lakh Cr+24% YoY
Housing Finance AUM₹42,204 Cr+58% YoY
Life Insurance AUM₹97,286 CrProfitable
Health Insurance Share14.2%#1 SAHI
💬 Which of these five businesses would be most valuable as a standalone IPO? My money’s on housing finance. What’s your take?
04 — Financials Overview
Q3 FY26: The Numbers That Make You Question Why You Didn’t Own This
Result type: Quarterly Results | Q3 FY26 Standalone EPS: ₹3.61 | Annualised EPS (Q3×4): ₹14.44 | Full-year FY25 EPS: ₹12.78
| Metric (₹ Cr) |
Q3 FY26
Dec 2025 |
Q3 FY25
Dec 2024 |
Q2 FY26
Sep 2025 |
YoY % |
QoQ % |
| Revenue (Standalone) | 9,661 | 7,609 | 7,897 | +26.9% | +22.4% |
| PAT (Standalone) | 966 | 689 | 686 | +40.3% | +40.8% |
| Revenue (Consolidated) | 11,952 | 9,381 | 10,595 | +27.4% | +12.8% |
| PAT (Consolidated) | 966 | 689 | 839 | +40.3% | +15.0% |
| EPS (₹, Standalone) | 3.61 | 2.58 | 2.57 | +40.0% | +40.5% |
The Math That Matters: Q3 standalone EPS of ₹3.61 annualizes to ₹14.44. Current P/E of 24.1x means the market is pricing in 5–6% annual growth, not the 28.8% CAGR that the business has actually delivered over five years. Full-year FY25 EPS was ₹12.78. If you extrapolate Q3’s run rate, FY26 could land at ₹15–16 EPS easily, which would adjust the P/E down to 20–22x range. Nothing’s changed operationally — the market is just being lazy. Revenue growth is 27% YoY (consolidated). Profit is growing faster than revenue because of operating leverage in the lending business.
05 — Valuation Discussion: Fair Value Range
Is ₹327 Expensive, or Are You Just Not Paying Attention?
Join 10,000+ investors who read this every week.
